和肽素与NT-proBNP预测缺血性卒中全因及心血管死亡
研究基于4215例急性缺血性卒中患者的前瞻性多中心队列,入院时标准化检测血浆和肽素与NT-proBNP水平。随访期间906例(20.1%,95%CI 18.9-21.2)死亡,其中心血管死亡589例(13.1%,95%CI 12.1-14.0)。多因素分析显示两标志物在同一模型中均具独立预后价值,联合加入可提升心血管死亡预测的AUC至0.86(95%CI 0.83-0.90)。
要点
- 和肽素与NT-proBNP第四分位均独立关联全因及心血管死亡。
- 两标志物联合加入后心血管死亡预测AUC升至0.86(95%CI 0.83-0.90)。
- NT-proBNP第四分位心血管死亡OR为2.58(95%CI 1.76-4.05)。
核心结论
- 和肽素与NT-proBNP或可作为中国急性缺血性卒中患者全因及心血管死亡的独立预后标志物。
研究设计与样本
- 前瞻性多中心观察性队列研究,纳入4215例急性缺血性卒中患者,入院时以标准化方法检测血浆和肽素与NT-proBNP水平。
主要发现
- 随访期间906例(20.1%,95%CI 18.9-21.2)死亡,其中心血管死亡589例(13.1%,95%CI 12.1-14.0)。
- 多因素分析中,和肽素第四分位与NT-proBNP第四分位在同一模型内对心血管死亡均有预后价值,OR分别为1.68(95%CI 1.22-2.49)与2.58(95%CI 1.76-4.05)。
- 同一模型中,和肽素第四分位与NT-proBNP第四分位对全因死亡的OR分别为1.48(95%CI 1.22-2.03)与2.47(95%CI 1.68-3.95)。
- 心血管死亡的ROC分析中,加入NT-proBNP指标时AUC为0.80至0.83(95%CI 0.79-0.87),同时加入两标志物后AUC升至0.86(95%CI 0.83-0.90)。
临床怎么用
- 对急性缺血性卒中患者入院时可考虑检测和肽素与NT-proBNP,以辅助识别1年内全因及心血管死亡高风险者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate long-term mortality in patients with acute ischemic stroke (AIS) by exploring the correlation between death and plasma concentrations of copeptin and N-terminal pro-B-type natriuretic peptide (NT-proBNP) in a cohort study. METHODS: In a prospective, multicenter observational study of 4,215 patients with AIS, copeptin and NT-proBNP levels were measured with a standardized method when patients were admitted to hospital. The primary endpoint was all-cause mortality or cardiovascular disease (CVD) mortality within 1 year. RESULTS: During a follow-up period, 906 patients (20.1%, 95% confidence interval [CI] 18.9-21.2) died, including 589 cases of CVD mortality (13.1%, 95% CI 12.1-14.0). With the use of a multivariate analysis, both markers were found to have prognostic value in the same model (CVD mortality: odds ratio [OR] for fourth quartile of copeptin and NT-proBNP 1.68 and 2.58, 95% CI 1.22-2.49 and 1.76-4.05, respectively; all-cause mortality: OR for fourth quartile of copeptin and NT-proBNP 1.48 and 2.47, 95% CI 1.22-2.03 and 1.68-3.95, respectively). In a receiver operating characteristics analysis of CVD mortality, the area under the curve varied from 0.80 to 0.83 (95% CI 0.79-0.87) when the index of NT-proBNP was added and increased to 0.86 (95% CI 0.83-0.90) when both markers were added. CONCLUSIONS: Copeptin and NT-proBNP may be useful independent prognostic markers of all-cause or CVD mortality in Chinese patients with AIS.
引用
- Tu WJ, Ma GZ, Ni Y, et al. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke. Neurology. 2017. PMID: 28424274. doi:10.1212/WNL.0000000000003937
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。